These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20124461)

  • 1. Probiotics for maintaining remission of ulcerative colitis in adults.
    Do VT; Baird BG; Kockler DR
    Ann Pharmacother; 2010 Mar; 44(3):565-71. PubMed ID: 20124461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics for maintenance of remission in ulcerative colitis.
    Naidoo K; Gordon M; Fagbemi AO; Thomas AG; Akobeng AK
    Cochrane Database Syst Rev; 2011 Dec; (12):CD007443. PubMed ID: 22161412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics for maintenance of remission in ulcerative colitis.
    Iheozor-Ejiofor Z; Kaur L; Gordon M; Baines PA; Sinopoulou V; Akobeng AK
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD007443. PubMed ID: 32128794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics for induction of remission in ulcerative colitis.
    Kaur L; Gordon M; Baines PA; Iheozor-Ejiofor Z; Sinopoulou V; Akobeng AK
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD005573. PubMed ID: 32128795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
    Kruis W; Fric P; Pokrotnieks J; Lukás M; Fixa B; Kascák M; Kamm MA; Weismueller J; Beglinger C; Stolte M; Wolff C; Schulze J
    Gut; 2004 Nov; 53(11):1617-23. PubMed ID: 15479682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine].
    Adam B; Liebregts T; Holtmann G
    Z Gastroenterol; 2006 Mar; 44(3):267-9. PubMed ID: 16514573
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.
    Kruis W; Schütz E; Fric P; Fixa B; Judmaier G; Stolte M
    Aliment Pharmacol Ther; 1997 Oct; 11(5):853-8. PubMed ID: 9354192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis.
    Matsuoka K; Uemura Y; Kanai T; Kunisaki R; Suzuki Y; Yokoyama K; Yoshimura N; Hibi T
    Dig Dis Sci; 2018 Jul; 63(7):1910-1919. PubMed ID: 29450747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.
    Scaldaferri F; Gerardi V; Mangiola F; Lopetuso LR; Pizzoferrato M; Petito V; Papa A; Stojanovic J; Poscia A; Cammarota G; Gasbarrini A
    World J Gastroenterol; 2016 Jun; 22(24):5505-11. PubMed ID: 27350728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients.
    Jonkers D; Penders J; Masclee A; Pierik M
    Drugs; 2012 Apr; 72(6):803-23. PubMed ID: 22512365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.
    Rembacken BJ; Snelling AM; Hawkey PM; Chalmers DM; Axon AT
    Lancet; 1999 Aug; 354(9179):635-9. PubMed ID: 10466665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.
    Regueiro M; Loftus EV; Steinhart AH; Cohen RD
    Inflamm Bowel Dis; 2006 Oct; 12(10):979-94. PubMed ID: 17012969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Astó E; Méndez I; Audivert S; Farran-Codina A; Espadaler J
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30704039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
    J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis.
    Wildt S; Nordgaard I; Hansen U; Brockmann E; Rumessen JJ
    J Crohns Colitis; 2011 Apr; 5(2):115-21. PubMed ID: 21453880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics and remission of ulcerative colitis: a systematic review.
    Zigra PI; Maipa VE; Alamanos YP
    Neth J Med; 2007 Dec; 65(11):411-8. PubMed ID: 18079563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial.
    Peng L; Zhong Y; Wang A; Jiang Z
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30224379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics for induction of remission in ulcerative colitis.
    Mallon P; McKay D; Kirk S; Gardiner K
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005573. PubMed ID: 17943867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escherichia coli Nissle 1917 in Ulcerative Colitis Treatment: Systematic Review and Meta-analysis.
    Losurdo G; Iannone A; Contaldo A; Ierardi E; Di Leo A; Principi M
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):499-505. PubMed ID: 26697577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis.
    Zocco MA; dal Verme LZ; Cremonini F; Piscaglia AC; Nista EC; Candelli M; Novi M; Rigante D; Cazzato IA; Ojetti V; Armuzzi A; Gasbarrini G; Gasbarrini A
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1567-74. PubMed ID: 16696804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.